Clinical Trials for Pancreatic Cancer

Find clinical trials for pancreatic cancer. Discover research opportunities and treatment options in your area.

376 Active Trials Found

Showing 376 trials on this page

Page 2 of 19

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

NCT ID: NCT06698458

This clinical trial is exploring a new treatment for pancreatic cancer that combines a special type of radiation therapy called Alpha DaRT with chemotherapy. The goal is to see if this combination ...

Recruiting

Phase: NA Type: interventional Locations: Rochester, Minnesota, United States, Bronx, New York, United States +14 more

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

NCT ID: NCT06758544

This clinical trial is studying a new treatment called VRT106, which is being tested alongside chemotherapy for patients with resectable pancreatic cancer. "Resectable" means that the cancer can be...

Recruiting

Phase: PHASE1 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, Guangdong, China

HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

NCT ID: NCT07131514

This clinical trial is testing a new combination of medicines—HRS-4642, gemcitabine, albumin-bound paclitaxel, and adebrelimab—to treat pancreatic cancer. The goal is to see if this treatment is sa...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

NCT ID: NCT06244771

This clinical trial is studying a new treatment called FMC-376 for patients with advanced solid tumors that have a specific genetic change known as the KRAS G12C mutation. These tumors can include ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Boston, Massachusetts, United States +17 more

DESTINY-PANTUMOUR04

NCT ID: NCT07124000

This clinical trial, called DESTINY-PANTUMOUR04, is studying a medicine called T-DXd to see how well it works in people with certain advanced cancers that have a specific marker called HER2-positiv...

Not yet recruiting

Type: observational

MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer

NCT ID: NCT07132060

This clinical trial is studying a new way to treat pancreatic cancer using a special type of radiation therapy guided by MRI scans. The goal is to see if giving higher doses of this targeted radiat...

Not yet recruiting

Phase: NA Type: interventional

Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer

NCT ID: NCT05836870

The Tele-PancFit trial is a study designed to see if a supervised exercise program conducted through video calls can help patients with pancreatic cancer who are undergoing chemotherapy. This trial...

Recruiting

Phase: PHASE3 Type: interventional Locations: Houston, Texas, United States

Cancer Loyalty Card Study 2 (CLOCS-2)

NCT ID: NCT06447064

The Cancer Loyalty Card Study 2 (CLOCS-2) is a research trial focused on improving early diagnosis of certain types of cancer, including pancreatic, colon, and ovarian cancers, among others. The st...

Recruiting

Type: observational Locations: London, United Kingdom

A Study of PHN-012 in Patients With Advanced Solid Tumors

NCT ID: NCT07127874

This clinical trial is testing a new treatment called PHN-012 for people with advanced cancers, including colon, lung, and pancreatic cancer, that have not responded to standard treatments. PHN-012...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: San Antonio, Texas, United States, Fairfax, Virginia, United States

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

NCT ID: NCT07126158

This clinical trial is studying a new treatment approach for people with advanced pancreatic cancer that cannot be removed by surgery. The study combines a special type of targeted radiation called...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Saint Louis, Missouri, United States

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

NCT ID: NCT07114666

This clinical trial is studying a new treatment option for people with pancreatic cancer who have already had surgery to remove their tumor. The study is testing a vaccine called XH001, designed to...

Not yet recruiting

Phase: NA Type: interventional Locations: Beijing, China

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

NCT ID: NCT07033689

This clinical trial is studying a new treatment called Suizenji, which uses focused ultrasound waves to heat and destroy cancer cells in the pancreas. This treatment is being tested for people with...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: San Francisco, California, United States

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT ID: NCT06695845

This clinical trial is studying a new treatment called zanidatamab for patients with certain types of solid tumors that have high levels of a protein called HER2. These tumors include breast, gastr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Houston, Texas, United States +20 more

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

NCT ID: NCT05663515

This clinical trial, called EXCEED, is studying the risk of pancreatic cancer in patients with type 2 diabetes who start a medication called exenatide compared to those who start other diabetes med...

Recruiting

Type: observational Locations: Paris, France, London, United Kingdom +6 more

A Study of Gene-edited GC203 TIL on the Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06828328

This clinical trial is studying a new treatment for pancreatic cancer called gene-edited tumor infiltrating lymphocytes (GC203 TIL). This therapy uses the patient’s own immune cells, which are modi...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers

NCT ID: NCT07026981

This clinical trial is studying a new way to help doctors detect and diagnose two types of cancer: pancreatic cancer and head and neck cancer. The researchers are testing a special imaging tool cal...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Cleveland, Ohio, United States

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

NCT ID: NCT06298916

This clinical trial is exploring a new imaging agent called 64Cu-LNTH-1363S, which is designed to help doctors see certain types of cancer better during scans. Specifically, the study is looking at...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cincinnati, Ohio, United States, Duarte, California, United States +3 more

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

NCT ID: NCT07108504

This clinical trial is studying a new treatment combination for people with a specific type of advanced pancreatic cancer that cannot be removed by surgery. The treatment combines a drug called LM-...

Not yet recruiting

Phase: PHASE2 Type: interventional

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

NCT ID: NCT07117032

This clinical trial is studying a new way to use a type of radiation therapy called stereotactic body radiotherapy (SBRT) to help reduce severe abdominal pain caused by pancreatic cancer or similar...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Cleveland, Ohio, United States

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

NCT ID: NCT07117045

This clinical trial is studying a new way to detect pancreatic cancer earlier using a special type of low-dose CT scan combined with artificial intelligence (AI). Pancreatic cancer is often found l...

Recruiting

Type: observational Locations: Shanghai, China, Shanghai, Shanghai, China +4 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions